PARP's catalytic activity is crucial in the context of cellular processes such as DNA repair and apoptosis. By understanding how PARP enzymes catalyze ADP-ribosylation, researchers can develop therapeutic strategies to modulate this activity. Inhibitors of PARP are already being used in the treatment of certain cancers, where they exploit the synthetic lethality in cancer cells deficient in other DNA repair pathways.
